RT Journal Article
T1 SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).
A1 Capdevila, Jaume
A1 Gomez, Ma Auxiliadora
A1 Guillot, Monica
A1 Paez, David
A1 Pericay, Carles
A1 Safont, Maria Jose
A1 Tarazona, Noelia
A1 Vera, Ruth
A1 Vidal, Joana
A1 Sastre, Javier
K1 Guideline
K1 Rectal cancer
K1 Total neoadjuvant therapy
AB The management of localized rectal cancer requires a multidisciplinary approach to optimize outcomes, reduce morbidity and prevent under or overtreatments. While early stages may obtain benefit of local resections without any additional therapies, locally advanced rectal cancer becomes a challenge defining the better sequential strategy of surgery, radiotherapy and chemotherapy. The latest results of international phase III studies have positioned the total neoadjuvant therapy as a potential new standard of care in high risk rectal cancers, however, the best schedule is still not well defined.
PB Springer
YR 2022
FD 2022-02-22
LK http://hdl.handle.net/10668/21130
UL http://hdl.handle.net/10668/21130
LA en
NO Capdevila J, Gómez MA, Guillot M, Páez D, Pericay C, Safont MJ, et al. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021). Clin Transl Oncol. 2022 Apr;24(4):646-657. doi: 10.1007/s12094-022-02816-9. Epub 2022 Mar 18. Erratum in: Clin Transl Oncol. 2022 Jul;24(7):1443-1444
DS RISalud
RD Apr 11, 2025